Product
Isoniazid and Rifampicin
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
A Phase 2b/c, Multi-Arm, 2-Stage, Duration Randomized Trial of the Efficacy and Safety of Two to Four Months Treatment With Regimens Containing Bedaquiline, OPC-167832, and Sutezolid, Plus Either Pretomanid or Delamanid, in Adults With Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2027-10-01